MSK Doctors has released its latest report exploring Arthrosamid aka Polyacrylamide hydrogel and its viability as a safe, lasting treatment for those battling knee osteoarthritis.

Sleaford, United Kingdom, January 6, 2025 -- MSK Doctors looks to improve public awareness regarding Arthrosamid, publishing a new report explaining the treatment’s benefits and implications for knee osteoarthritis sufferers. Available as an injection at private clinics throughout the United Kingdom, MSK Doctors notes that the procedure is quickly gaining steam in medical circles for its effectiveness.

For more information see https://mskdoctors.com/treatments/arthrosamid

Wider science supports MSK Doctors’ assertion that Arthrosamid can facilitate an accelerated recovery stage for those dealing with the condition, says MSK Doctors. Its report cites numerous studies that have compared Arthrosamid favourably to alternative treatments - including hyaluronic acid - in terms of its ability to help manage and even reduce pain.

As outlined in the report, Arthrosamid works by bolstering the connective tissue around the knee - an area also known as the synovial membrane. The intended result is a stronger overall function in the knee, an effect that extensive research has highlighted among patients who’ve opted for the procedure, adds MSK Doctors.

“Arthrosamid is a non-degradable and non-resorbable hydrogel composed of 2.5% cross-linked polyacrylamide and 97.5% non-pyrogenic water,” explains the report. “It is administered via intra-articular injection into the knee joint. The hydrogel serves as a scaffold for the synovial membrane.”

The focus of recent investigations has largely been on determining the procedure’s safety for patients along with the longevity of its impact. MSK Doctors is enthusiastic on this note, with its report pointing to studies that project Arthrosamid’s positive effects as lasting for two years, minimum - a crucial window of relief and recovery for osteoarthritis sufferers.

In addition, the report links to a strategic review originally published by a team of researchers including Professor Paul Lee, one of MSK Doctors’ foremost Consultant Orthopaedic Surgeons. Based on the results of more than 400 patients, this study found no lasting adverse effects stemming from Arthrosamid injections - instead concluding that the treatment is both safe and viable.

The report also illustrates successful outcomes by patients, young and old alike, who’ve received care with Arthrosamid. The team notes that the procedure has improved their lives while restoring their mobility and alleviating their pain.

As such, MSK Doctors invites patients to connect with clinicians using its platform, established to help visitors find locally-based private clinics across the UK with demonstrable expertise on the suitability of Arthrosamid and other treatments for knee osteoarthritis.

Interested parties can access MSK Doctors’ full network of musculoskeletal specialists at https://mskdoctors.com/

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89150059

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.